BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9883909)

  • 1. Kinetic properties and stereospecificity of the monomeric dUTPase from herpes simplex virus type 1.
    Bergman AC; Nyman PO; Larsson G
    FEBS Lett; 1998 Dec; 441(2):327-30. PubMed ID: 9883909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dUTPases from herpes simplex virus type 1 and mouse mammary tumour virus are less specific than the Escherichia coli enzyme.
    Björnberg O; Nyman PO
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3107-11. PubMed ID: 9000104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. dUTPase from the retrovirus equine infectious anemia virus: specificity, turnover and inhibition.
    Nord J; Larsson G; Kvassman JO; Rosengren AM; Nyman PO
    FEBS Lett; 1997 Sep; 414(2):271-4. PubMed ID: 9315700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mercury (II) compounds on the activity of dUTPases from various sources.
    Williams MV
    Mol Pharmacol; 1986 Mar; 29(3):288-92. PubMed ID: 3005836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic characterization of dUTPase from Escherichia coli.
    Larsson G; Nyman PO; Kvassman JO
    J Biol Chem; 1996 Sep; 271(39):24010-6. PubMed ID: 8798636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
    Harris JM; McIntosh EM; Muscat GE
    J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient kinetics of ligand binding and role of the C-terminus in the dUTPase from equine infectious anemia virus.
    Nord J; Kiefer M; Adolph HW; Zeppezauer MM; Nyman PO
    FEBS Lett; 2000 Apr; 472(2-3):312-6. PubMed ID: 10788633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic properties and inhibition of the dimeric dUTPase-dUDPase from Campylobacter jejuni.
    Musso-Buendía JA; Vidal AE; Kasinthan G; Nguyen C; Carrero-Lérida J; Ruiz-Pérez LM; Wilson K; Johansson NG; Gilbert IH; González-Pacanowska D
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):111-6. PubMed ID: 18608754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. dUTPase from the retrovirus equine infectious anemia virus: high-level expression in Escherichia coli and purification.
    Bergman AC; Björnberg O; Nord J; Rosengren AM; Nyman PO
    Protein Expr Purif; 1995 Jun; 6(3):379-87. PubMed ID: 7663176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2'-deoxyuridine 5'-(alpha,beta-imido) triphosphate: a substrate analogue and potent inhibitor of dUTPase.
    Persson T; Larsson G; Nyman PO
    Bioorg Med Chem; 1996 Apr; 4(4):553-6. PubMed ID: 8735843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of deoxyuridine 5'-triphosphate nucleotidohydrolase from Trypanosoma cruzi.
    Bernier-Villamor V; Camacho A; Hidalgo-Zarco F; Pérez J; Ruiz-Pérez LM; González-Pacanowska D
    FEBS Lett; 2002 Aug; 526(1-3):147-50. PubMed ID: 12208522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of homotrimeric dUTPases by the 3'-azido derivative of dideoxy-UTP.
    Palmén LG; Kvassman JO
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):146-50. PubMed ID: 19761402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and mutational studies of equine infectious anemia virus dUTPase.
    Shao H; Robek MD; Threadgill DS; Mankowski LS; Cameron CE; Fuller FJ; Payne SL
    Biochim Biophys Acta; 1997 May; 1339(2):181-91. PubMed ID: 9187238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic properties and inhibition of the dimeric dUTPase-dUDPase from Leishmania major.
    Hidalgo-Zarco F; Camacho AG; Bernier-Villamor V; Nord J; Ruiz-Pérez LM; González-Pacanowska D
    Protein Sci; 2001 Jul; 10(7):1426-33. PubMed ID: 11420444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic properties and specificity of trimeric Plasmodium falciparum and human dUTPases.
    Quesada-Soriano I; Casas-Solvas JM; Recio E; Ruiz-Pérez LM; Vargas-Berenguel A; González-Pacanowska D; García-Fuentes L
    Biochimie; 2010 Feb; 92(2):178-86. PubMed ID: 19879316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a herpes simplex virus type 2 deoxyuridine triphosphate nucleotidohydrolase and mapping of a gene conferring type specificity for the enzyme.
    Williams MV; Parris DS
    Virology; 1987 Feb; 156(2):282-92. PubMed ID: 3027979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double role for a strictly conserved serine: further insights into the dUTPase catalytic mechanism.
    Palmén LG; Becker K; Bülow L; Kvassman JO
    Biochemistry; 2008 Jul; 47(30):7863-74. PubMed ID: 18597482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the Escherichia coli dUTPase in complex with a substrate analogue (dUDP).
    Larsson G; Svensson LA; Nyman PO
    Nat Struct Biol; 1996 Jun; 3(6):532-8. PubMed ID: 8646539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminus of dUTPase: observation on flexibility using NMR.
    Nord J; Nyman P; Larsson G; Drakenberg T
    FEBS Lett; 2001 Mar; 492(3):228-32. PubMed ID: 11257499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific derivatization of the active site tyrosine in dUTPase perturbs ligand binding to the active site.
    Vertessy BG; Persson R; Rosengren AM; Zeppezauer M; Nyman PO
    Biochem Biophys Res Commun; 1996 Feb; 219(2):294-300. PubMed ID: 8604980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.